Brexpiprazole as an Adjunctive Treatment to Paroxetine or Sertraline in Adult Patients Suffering From Post-traumatic Stress Disorder (PTSD)

Summary

To evaluate the efficacy of brexpiprazole as adjunctive treatment to paroxetine (PAR) or sertraline (SER) on PTSD symptoms.

Timeline

Start

2013-12

Primary completion

2015-10

Completion

2015-10

Outcome

Outcome not reported

Stopped: “The study was terminated due to challenges with patient eligibility; the decision to terminate was not based on any safety concerns”

Drugs

Indications